Interestingly, lower Hsp90α levels were found in NAFLD patients compared to non-NAFLD patients (median 11.41 ng/mL (3.59-119.85) versus 18.83 ng/mL (0-105.4), p = 0.049, Mann-Whitney U test, Figure 1). Here, HSP90AA1 is linked to metabolic dysfunction-associated steatotic liver disease.